GLP-1 Weight Regain: What the Tirzepatide Trials Show

In the Lilly-funded SURMOUNT-4 trial, published online in JAMA in December 2023, 670 adults with overweight or obesity, without diabetes, lost an average of 20.9% of their starting weight during 36 weeks of tirzepatide treatment.

Over the next 52 weeks, people who continued treatment lost another 5.5%. People switched to placebo gained 14%, measured against their weight at the time of the switch. That means a 14% increase in body weight, not merely regaining 14% of the pounds they had lost. JAMA Network

Here's the detail worth paying attention to: diet and physical activity counseling continued in both groups. JAMA Network

So yes, encourage better habits. Absolutely. But the trial does not establish that people regained weight because they suddenly stopped trying.

Calling every rebound a discipline problem is a hell of a conclusion to draw from a study that never showed that.

A later analysis, published online in November 2025, looked at 308 SURMOUNT-4 participants who had lost at least 10% of their weight before stopping tirzepatide.

Within a year, 82.5% regained at least a quarter of the weight they had lost. Greater regain was also associated with larger reversals in improvements in blood pressure, blood sugar, and other health measures. JAMA Network

That is a serious finding. It also does not mean 82.5% of people gained everything back.

For example, losing 40 pounds and regaining 10 meets that "quarter regained" threshold. That's an illustration of the math, not a prediction for any individual.

We can talk about the risk without turning the numbers into a horror story.

Here's a reasonable question: once someone has lost weight, could a lower dose help them maintain it instead of stopping treatment entirely?

Lilly's newer SURMOUNT-MAINTAIN trial explored that idea. Results were published in May 2026. After 60 weeks of tirzepatide, participants continued their maximum tolerated dose of 10 or 15 mg weekly, stepped down to 5 mg weekly, or switched to placebo for another 52 weeks. Eli Lilly and Company

At the end, the estimated average weight reductions from their original starting weight were:

These are total weight reductions from before treatment. The lower-dose group kept more weight off than the placebo group, but still regained some weight. Continuing the previous dose preserved more progress. Zepbound (tirzepatide)

That gives lower-dose maintenance a credible place in the conversation. For how the options differ at the receptor level, see our GLP-1 peptides compared guide.

But let's get the terminology right. The 5 mg dose is an approved Zepbound maintenance dose. Calling it "microdosing" blurs the distinction between a studied treatment and much smaller, nonstandard doses. Lilly prescribing information

SURMOUNT-MAINTAIN did not test tiny doses below approved maintenance levels or stretching out the time between injections. It also enrolled people who had already responded to and tolerated tirzepatide. Those results cannot tell everyone what dose they should take next. Zepbound (tirzepatide)

Lower-dose maintenance may be an option to discuss with a prescriber. Microdosing still needs stronger evidence before anyone sells it as the answer.

Lilly funded these trials, which deserves disclosure. Read the results with that in mind, including the regain that occurred in the lower-dose group. A press-release headline should never do all your thinking for you.

If treatment makes managing food feel easier, use that opportunity.

Learn what a satisfying meal looks like. Find exercise you can repeat when work gets busy. Build a routine that survives a stressful Tuesday.

A 2025 advisory from four professional societies recommends establishing nutrition and lifestyle practices before and during GLP-1 treatment. It also acknowledges that the specific habits that prevent regain after stopping have not been rigorously established. PMC

That is a reason to be practical, not hopeless.

• Eat for nourishment. Include protein and fiber-rich foods, and get help if reduced appetite makes it difficult to eat enough.
• Build a strength routine. Adequate protein and resistance training support muscle preservation during weight loss. A protein shake cannot do the training for you.
• Make movement repeatable. Choose walking, cycling, swimming, or another activity you can keep doing.
• Take sleep seriously. Make a consistent sleep routine part of your plan. PMC

Start small enough that these habits fit your actual life. "I'll become a completely different person when I stop the medication" is asking a lot of future you.

There is some encouraging exercise research. A small follow-up study involving liraglutide suggested that combining medication with structured exercise could improve longer-term outcomes. Regain still occurred, and the difference in post-treatment regain between the combination and medication-only groups was uncertain. It studied a different drug and does not prove exercise prevents rebound. University of Copenhagen Research Portal

The aim is to enter a transition with useful routines already in place. Nobody can honestly promise those routines will make stopping easy or guarantee that all the weight stays off.

"Lose 50 pounds" is a goal. It leaves a lot unanswered.

What happens if appetite becomes harder to manage? What if insurance coverage changes? What if side effects make the current treatment difficult? Who is checking in after a medication change?

Those are conversations to have with the prescriber before you are trying to solve everything at once. Depending on response, side effects, health needs, and cost, the plan may involve continued treatment, an adjustment, or another approach. Healthy eating and activity remain useful whether medication continues or stops. NIDDK

Agree on follow-up, how to monitor the weight trend, and what would prompt a reassessment. A normal fluctuation should not become a personal failure, and a persistent trend deserves attention.

If someone still needs treatment after building good habits, their effort still counts.

If you are working out what a dose actually measures in a syringe, our peptide dosage calculator handles that math.

We should be able to celebrate weight loss without pretending the next phase will take care of itself.

Build the habits while you have support. Ask about maintenance before changing treatment. Stay curious about lower-dose options, and demand evidence when someone promises a microdosing shortcut.

And maybe retire the idea that needing continued treatment makes someone weak.

Your goal weight is a milestone. It is a terrible substitute for a maintenance plan.

Educational content. Medication changes should be made with a licensed prescriber.